241 related articles for article (PubMed ID: 31099643)
21. The role of human papillomavirus on the prognosis and treatment of oropharyngeal carcinoma.
Fung N; Faraji F; Kang H; Fakhry C
Cancer Metastasis Rev; 2017 Sep; 36(3):449-461. PubMed ID: 28812214
[TBL] [Abstract][Full Text] [Related]
22. [De-escalation concepts for chemoradiotherapy of HPV-positive oropharyngeal carcinomas: pros and cons].
Rühle A; Nicolay NH
HNO; 2021 Apr; 69(4):278-284. PubMed ID: 33048200
[TBL] [Abstract][Full Text] [Related]
23. Cancer of the Oropharynx and the Association with Human Papillomavirus.
Rettig EM; Sethi RKV
Hematol Oncol Clin North Am; 2021 Oct; 35(5):913-931. PubMed ID: 34244016
[TBL] [Abstract][Full Text] [Related]
24. Should We De-escalate the Treatment for HPV-Positive Tumors?
Dietz A; Wichmann G; Wiegand S
Recent Results Cancer Res; 2017; 206():173-181. PubMed ID: 27699538
[TBL] [Abstract][Full Text] [Related]
25. Therapeutic strategies for systemic therapies of human papillomavirus-related oropharyngeal cancer.
Hung TKW; Ho AL; Pfister DG
J Surg Oncol; 2021 Nov; 124(6):952-961. PubMed ID: 34585389
[TBL] [Abstract][Full Text] [Related]
26. Management of Oropharyngeal Cancer in the HPV Era.
Naghavi AO; Strom TJ; Ahmed KA; Echevarria MI; Abuodeh YA; Venkat PS; Frakes JM; Harrison LB; Trotti AM; Caudell JJ
Cancer Control; 2016 Jul; 23(3):197-207. PubMed ID: 27556659
[TBL] [Abstract][Full Text] [Related]
27. The potential impact of prophylactic human papillomavirus vaccination on oropharyngeal cancer.
Guo T; Eisele DW; Fakhry C
Cancer; 2016 Aug; 122(15):2313-23. PubMed ID: 27152637
[TBL] [Abstract][Full Text] [Related]
28. De-Escalation Treatment for Human Papillomavirus-Related Oropharyngeal Cancer: Questions for Practical Consideration.
Chen AM
Oncology (Williston Park); 2023 Jul; 37(7):281-287. PubMed ID: 37499250
[TBL] [Abstract][Full Text] [Related]
29. Human papilloma virus in locally advanced stage III/IV squamous cell cancer of the oropharynx and impact on choice of therapy.
Ihloff AS; Petersen C; Hoffmann M; Knecht R; Tribius S
Oral Oncol; 2010 Oct; 46(10):705-11. PubMed ID: 20843732
[TBL] [Abstract][Full Text] [Related]
30. Evolving Treatment Paradigms for Oropharyngeal Squamous Cell Carcinoma.
Cleary RK; Cmelak AJ
J Glob Oncol; 2018 Sep; 4():1-9. PubMed ID: 30241193
[TBL] [Abstract][Full Text] [Related]
31. Oropharyngeal cancer - is it time to change management according to human papilloma virus status?
Mehanna H; Olaleye O; Licitra L
Curr Opin Otolaryngol Head Neck Surg; 2012 Apr; 20(2):120-4. PubMed ID: 22327790
[TBL] [Abstract][Full Text] [Related]
32. Controversies in Postoperative Irradiation of Oropharyngeal Cancer After Transoral Surgery.
Yom SS; Mallen-St Clair J; Ha PK
Surg Oncol Clin N Am; 2017 Jul; 26(3):357-370. PubMed ID: 28576176
[TBL] [Abstract][Full Text] [Related]
33. Oropharyngeal cancer and human papilloma virus: evolving diagnostic and management paradigms.
Buckley L; Gupta R; Ashford B; Jabbour J; Clark JR
ANZ J Surg; 2016 Jun; 86(6):442-7. PubMed ID: 26687076
[TBL] [Abstract][Full Text] [Related]
34. Human papillomavirus in oropharyngeal cancer: The changing face of a disease.
Mallen-St Clair J; Alani M; Wang MB; Srivatsan ES
Biochim Biophys Acta; 2016 Dec; 1866(2):141-150. PubMed ID: 27487173
[TBL] [Abstract][Full Text] [Related]
35. [Update on HPV-associated head and neck cancer-highlights from the 2019 ASCO Annual Meeting].
Tribius S; Würdemann N; Laban S; Hoffmann TK; Sharma SJ; Klussmann JP
HNO; 2019 Dec; 67(12):912-917. PubMed ID: 31701169
[TBL] [Abstract][Full Text] [Related]
36. TRAF3/CYLD mutations identify a distinct subset of human papillomavirus-associated head and neck squamous cell carcinoma.
Hajek M; Sewell A; Kaech S; Burtness B; Yarbrough WG; Issaeva N
Cancer; 2017 May; 123(10):1778-1790. PubMed ID: 28295222
[TBL] [Abstract][Full Text] [Related]
37. HPV-related oropharyngeal cancers: from pathogenesis to new therapeutic approaches.
Tornesello ML; Perri F; Buonaguro L; Ionna F; Buonaguro FM; Caponigro F
Cancer Lett; 2014 Sep; 351(2):198-205. PubMed ID: 24971935
[TBL] [Abstract][Full Text] [Related]
38. Sexual health in oral oncology: breaking the news to patients with human papillomavirus-positive oropharyngeal cancer.
Evans M; Powell NG
Head Neck; 2014 Nov; 36(11):1529-33. PubMed ID: 24913820
[TBL] [Abstract][Full Text] [Related]
39. Impact of cisplatin dose intensity on human papillomavirus-related and -unrelated locally advanced head and neck squamous cell carcinoma.
Spreafico A; Huang SH; Xu W; Granata R; Liu CS; Waldron JN; Chen E; Ringash J; Bayley A; Chan KK; Hope AJ; Cho J; Razak AA; Hansen A; Jang R; Perez-Ordonez B; Weinreb I; Bossi P; Orlandi E; Licitra LF; Song Y; O'Sullivan B; Siu LL; Kim J
Eur J Cancer; 2016 Nov; 67():174-182. PubMed ID: 27669504
[TBL] [Abstract][Full Text] [Related]
40. Confirmation of proposed human papillomavirus risk-adapted staging according to AJCC/UICC TNM criteria for positive oropharyngeal carcinomas.
Horne ZD; Glaser SM; Vargo JA; Ferris RL; Balasubramani GK; Clump DA; Heron DE; Beriwal S
Cancer; 2016 Jul; 122(13):2021-30. PubMed ID: 27111669
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
